Education
About Us
Working with TipRanks
Follow Us
Ayr Wellness (AYRWF)
OTHER OTC:AYRWF
AYRWF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.09 - $2.60
Previous CloseN/A
Volume133.29K
Average Volume (3M)212.15K
Market Cap
$13.18M
Enterprise Value$599.61M
Total Cash (Recent Filing)$35.48M
Total Debt (Recent Filing)$621.88M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Aug 14, 2025EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding108,759,750
10 Day Avg. Volume398,543
30 Day Avg. Volume212,146
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.03
Price to Sales (P/S)0.00
P/FCF Ratio-0.87
Enterprise Value/Market Cap45.51
Enterprise Value/Revenue0.32
Enterprise Value/Gross Profit3.39
Enterprise Value/Ebitda6.12
Forecast
1Y Price Target
$0.29Price Target Upside81.25% Upside
Rating ConsensusHold
Number of Analyst Covering0
Ayr Wellness News
PremiumCompany Announcements
AYR Wellness Extends Waiver Agreement to Strengthen Financial Position
PremiumCompany Announcements
AYR Wellness Extends Waiver Agreement to Strengthen Financial Position
PremiumCompany Announcements
AYR Wellness Delays Q1 2025 Financial Filings Amid Debt NegotiationsOptions Prices
Currently, No data available
---
Ownership Overview
18.41% Insiders
0.63% Other Institutional Investors
80.96% Public Companies and Individual Investors
AYRWF FAQ
What was Ayr Wellness’s price range in the past 12 months?
Ayr Wellness lowest stock price was $0.09 and its highest was $2.60 in the past 12 months.
What is Ayr Wellness’s market cap?
Ayr Wellness’s market cap is $13.18M.
When is Ayr Wellness’s upcoming earnings report date?
Ayr Wellness’s upcoming earnings report date is Aug 14, 2025 which is in 26 days.
How were Ayr Wellness’s earnings last quarter?
Ayr Wellness released its earnings results on May 21, 2025. The company reported -$0.357 earnings per share for the quarter, missing the consensus estimate of -$0.32 by -$0.037.
Is Ayr Wellness overvalued?
According to Wall Street analysts Ayr Wellness’s price is currently Undervalued.
Does Ayr Wellness pay dividends?
Ayr Wellness does not currently pay dividends.
What is Ayr Wellness’s EPS estimate?
Ayr Wellness’s EPS estimate is -0.34.
How many shares outstanding does Ayr Wellness have?
Ayr Wellness has 108,759,750 shares outstanding.
What happened to Ayr Wellness’s price movement after its last earnings report?
Ayr Wellness reported an EPS of -$0.357 in its last earnings report, missing expectations of -$0.32. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ayr Wellness?
Currently, no hedge funds are holding shares in AYRWF
Ayr Wellness Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.29 (81.25% Upside)
$0.29 (81.25% Upside)
Blogger Sentiment
Bullish
AYRWF Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-92.74%
12-Months-Change
Fundamentals
Return on Equity
-74.75%
Trailing 12-Months
Asset Growth
-11.52%
Trailing 12-Months
Company Description
Ayr Wellness
Ayr Wellness Inc., a vertically-integrated cannabis multi-state operator, cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizers. It also provides administrative, consulting, and operations support services to licensed cannabis companies. As of November 1, 2022, Ayr Wellness Inc. operated 52 dispensaries. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.
AYRWF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted strategic moves to strengthen the business through operational streamlining and market expansion, particularly in Ohio. However, significant challenges persist, including price compression and various operational difficulties, leading to a decline in profitability and substantial impairment charges.Read More>Technical Analysis
OrganiGram Holdings
―
Auxly Cannabis Group
―
MediPharm Labs
―
Planet 13 Holdings
―
TerrAscend Corp
―